BOULDER, Colo., June 13, 2017 -- UMF Group Inc. (OTC Pink:UMFG) (“the Company”) is pleased to announce the implementation of product quality control testing. We have implemented the most stringent quality control system in the industry and intend to continue to set standards. Only 3rd-party laboratories are used to analyse all our ingredients and finished products.
Our oil is extracted through proprietary whole plant extraction techniques (patent application in progress). To determine the purity and potency of every batch, each extraction is analyzed through a High Pressure Liquid Chromatography (HPLC) test for aerobic organisms, yeast, fungus, E. coli, and heavy toxic metals, and is also analyzed for the cannabidiol (+ other cannabinoid) potency. The extract is further analyzed for its potency and purity by a third party. The laboratory we use adheres to international ISO standards.
With these multiple analyses performed it ensures that the cannabidiol (CBD) content is pure and consistent throughout every batch made. Naturally present are also amino acids, carbohydrates, vitamins (including B1, B2, B6, D), Omega 3 and 6, trace minerals (including iron, zinc, calcium, magnesium, potassium), beta-carotene, flavanoids, ketones, alkanes, glycosides and terpenes.
All our oils contain the same amount of quality Extract, but are uniquely blended. The extraction process we use to make our oils provides us with a full spectrum extract containing over 80 different phyto-cannabinoids, including CBD, CBC, CBG, CBG-A, CBC-A, and many others. Our Medicinal Marijuana oils happen to naturally contain high levels of cannabidiol ( CBD ) because it’s made from our proprietary full spectrum “whole plant” extract.
FORWARD LOOKING STATEMENT
This news release includes forward-looking statements that reflect UMF Group Inc. current expectations about its future results, performance, prospects and opportunities UMF Group Inc. has tried to identify these forward-looking statements by using words and phrases such as "may", "will", "expects", "anticipates", "believes", "intends", "estimates", "should", "typical", "we are confident" or similar expressions. These forward-looking statements are based on information currently available to UMF Group Inc. and are subject to a number of risks, uncertainties and other factors that could cause the Company's actual results, performance, prospects of opportunities in the remainder of 2017 and beyond, to differ materially from those expressed in, or implied by, these forward-looking statements.
Contact: Sean Ross, President UMF Group Inc. [email protected]


Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition
Qantas to Sell Jetstar Japan Stake as It Refocuses on Core Australian Operations
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Elon Musk’s SpaceX Acquires xAI in Historic Deal Uniting Space and Artificial Intelligence
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
CK Hutchison Unit Launches Arbitration Against Panama Over Port Concessions Ruling
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Boeing Signals Progress on Delayed 777X Program With Planned April First Flight
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 



